Intellia Therapeutics, Inc.
US ˙ NasdaqGM ˙ US45826J1051

SecurityNTLA / Intellia Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership966,293 shares
Latest Disclosed Value $ 12,387,876
Northern Trust Corp reports 10.74% increase in ownership of NTLA / Intellia Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 966,293 shares of Intellia Therapeutics, Inc. (US:NTLA) valued at $12,387,876 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 872,579 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 10.74% during the quarter. The current value of the position is $13,083,607 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 966,293 93,714 10.74 12,388 57.92 0.0003
2026-02-17 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 872,579 -33,713 -3.72 7,844 -49.88 0.0010
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 906,292 -2,704 -0.30 15,652 83.57 0.0020
2025-08-13 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 908,996 -8,765 -0.96 8,526 30.67 0.0012
2025-05-13 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 917,761 -61,376 -6.27 6,525 -42.84 0.0010
2025-02-14 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 979,137 112,847 13.03 11,417 -35.87 0.0016
2024-11-13 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 866,290 30,939 3.70 17,802 -4.78 0.0029
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 835,351 -35,944 -4.13 18,695 -22.00 0.0032
2024-05-14 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 871,295 -15,093 -1.70 23,969 -11.31 0.0041
2024-02-13 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 886,388 -33,999 -3.69 27,026 -7.14 0.0049
2023-11-13 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 920,387 1,865 0.20 29,103 -22.31 0.0056
2023-08-11 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 918,522 157,032 20.62 37,457 31.98 0.0072
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 761,490 -8,370 -1.09 28,381 5.66 0.0056
2023-02-13 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 769,860 65,086 9.24 26,860 -31.89 0.0056
2022-11-14 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 704,774 717 0.10 39,439 8.22 0.0090
2022-08-12 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 704,057 14,446 2.09 36,442 -27.28 0.0078
2022-05-13 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 689,611 -48,192 -6.53 50,114 -42.56 0.0088
2022-02-08 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 737,803 -5,915 -0.80 87,239 -12.56 0.0143
2021-11-15 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 743,718 36,421 5.15 99,770 -12.88 0.0177
2021-08-13 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 707,297 62,476 9.69 114,518 121.29 0.0202
2021-05-12 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 644,821 2,914 0.45 51,750 48.20 0.0096
2021-02-11 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 641,907 -9,500 -1.46 34,919 169.64 0.0068
2020-11-16 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 651,407 179,775 38.12 12,950 30.62 0.0028
2020-08-14 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 471,632 -39,259 -7.68 9,914 58.65 0.0023
2020-05-14 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 510,891 8,481 1.69 6,249 -15.21 0.0018
2020-02-14 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 502,410 11,116 2.26 7,370 12.36 0.0016
2019-11-13 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 491,294 83,346 20.43 6,559 -1.78 0.0016
2019-08-13 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 407,948 13,737 3.48 6,678 -0.82 0.0016
2019-05-13 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 394,211 4,281 1.10 6,733 26.51 0.0017
2019-02-12 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 389,930 -3,839 -0.97 5,322 -52.77 0.0015
2018-11-14 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 393,769 29,598 8.13 11,269 13.11 0.0028
2018-09-18 2018-06-30 13F/A-1 INTELLIA THERAPEUTICS COM 45826J105 364,171 179,553 97.26 9,963 155.86 0.0025
2018-08-14 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 366,673 182,055 10,032
2018-05-09 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 184,618 1,782 0.97 3,894 10.81 0.0010
2018-02-14 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 182,836 30,677 20.16 3,514 -7.06 0.0009
2017-11-13 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 152,159 115,563 315.78 3,781 546.32 0.0010
2017-08-11 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 36,596 -39,699 -52.03 585 -45.58 0.0002
2017-05-12 2017-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 76,295 -1,664 -2.13 1,075 5.19 0.0003
2017-02-13 2016-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 77,959 2,563 3.40 1,022 -20.34 0.0003
2016-11-09 2016-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 75,396 -287 -0.38 1,283 -20.56 0.0004
2016-08-12 2016-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 75,683 75,683 1,615 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.